Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic Acid vs Vitamin E in NASH
NCT05573204Phase 2Active, not recruiting
- Sponsor
- Tanta University
- Start
- Sep 2021
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of obeticholic acid in Nonalcoholic steatohepatitis (NASH), sponsored by Tanta University. Started Sep 2021; status: active, not recruiting.
02
Drugs
obeticholic acid
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05573204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05573204.